Back
Keros Therapeutics Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
14
KROS
Keros Therapeutics
Last Price:
$13.48
Seasonality Move:
8.33%
7 Day Trial
ALL ACCESS PASS
$
7

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.61 | Sell |
20-day SMA: | 14.17 | Sell |
50-day SMA: | 13.92 | Sell |
200-day SMA: | 29.4 | Sell |
8-day EMA: | 13.7 | Sell |
20-day EMA: | 13.93 | Sell |
50-day EMA: | 13.9 | Sell |
200-day EMA: | 24.43 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 42.54 | Sell |
Chaikin Money Flow: | -73014 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.66 - 14.64) | Sell |
Bollinger Bands (100): | (10.81 - 14.07) | Buy |
Keros Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 13.49 while KROS 8-day simple moving average is 13.61, which is a Sell signal.
-
The stock price of KROS is 13.49 while Keros Therapeutics 20-day SMA is 14.17, which makes it a Sell.
-
Keros Therapeutics 50-day simple moving average is 13.92 while KROS share price is 13.49, making it a Sell technically.
-
KROS stock price is 13.49 and Keros Therapeutics 200-day simple moving average is 29.40, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
14
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $13.49. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
547.9M
Price in USD:
13.49
Share Volume:
657.1K
Keros Therapeutics 52-Week Range
52-Week High:
72.37
52-Week Low:
9.12
Sell
14
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 13.49 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 13.49 while KROS 8-day exponential moving average is 13.70, which is a Sell signal.
-
The stock price of KROS is 13.49 while Keros Therapeutics 20-day EMA is 13.93, which makes it a Sell.
-
Keros Therapeutics 50-day exponential moving average is 13.90 while KROS share price is 13.49, making it a Sell technically.
-
KROS stock price is 13.49 and Keros Therapeutics 200-day simple moving average is 24.43, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Keros Therapeutics is a Sell
-
Keros Therapeutics Relative Strength Index (RSI) is 42.54, which suggest Keros Therapeutics is oversold
-
The Bollinger Bands (25) for Keros Therapeutics is (13.66 - 14.64), which suggest Keros Therapeutics is a Buy
-
The Bollinger Bands (100) for Keros Therapeutics is (10.81 - 14.07), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.